Urgent high quality communications from across the chemical sciences.
Impact Factor 6.378 100 Issues per Year Indexed in MEDLINE
Communication

An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors – potential therapeutics in cancer and neurodegeneration

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
School of Chemistry, University of Nottingham, University Park, Nottingham, UK
E-mail: c.j.moody@nottingham.ac.uk;
Fax: +44 (0)115 951 3564
Chem. Commun., 2013,49, 8441-8443

DOI: 10.1039/C3CC43457E
Received 09 May 2013, Accepted 10 Jun 2013
First published online 10 Jun 2013
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
| | | | | | More
Open Access
Open Access
Please wait while Download options loads
Download Citation
 
 

Supplementary Info